Dr. Andrea Rosati is an Associate Professor of Psychiatry at the University of California, San Francisco. She served as a Sub-Investigator, Study Therapist, and Study Physician in Phase 2 and 3 MAPS-sponsored clinical trials of MDMA-AT for PTSD at UCSF, and as an Associate Supervisor and Training Assistant in the MAPS Therapy Training Program. She is also involved in a number of other clinical trials of psychedelics, including as a Study Physician in multiple psilocybin studies and as a Principal Investigator in a study of ketamine-assisted therapy for cancer patients at UCSF. She is also an instructor in the Psychedelic-Assisted Psychotherapies Training Program at Polaris Insight Center in San Francisco.